Koechlin H, Werdelis C, Barke A, Korwisi B, von Kanel R, Wagner J
Pain Rep. 2024; 10(1):e1216.
PMID: 39664707
PMC: 11630933.
DOI: 10.1097/PR9.0000000000001216.
Hara T, Suzuki K, Okamura Y, Chiba K, Sato R, Matsushita Y
Int J Clin Oncol. 2024; 29(12):1931-1936.
PMID: 39472358
DOI: 10.1007/s10147-024-02633-w.
Waddell T, Pillai M, Armitage K, Graham D, Moran M, Dilleen M
Future Oncol. 2024; 20(33):2547-2558.
PMID: 39382446
PMC: 11534105.
DOI: 10.1080/14796694.2024.2385882.
Jakobsson M, Strambi A, Nilsson F, Arpegard J, Dalen J
Future Oncol. 2024; 20(20):1385-1392.
PMID: 39057291
PMC: 11376413.
DOI: 10.1080/14796694.2024.2351352.
Remiro-Azocar A, Heath A, Baio G
BMC Med Res Methodol. 2024; 24(1):32.
PMID: 38341552
PMC: 10858574.
DOI: 10.1186/s12874-024-02157-x.
Deficiencies in reporting inclusion/exclusion criteria and characteristics of patients in randomized controlled trials of therapeutic interventions in pressure injuries: a systematic methodological review.
Miranda J, Abbade L, Abbade J, Thabane L, Mbuagbaw L, Pascon G
Int Wound J. 2023; .
PMID: 37904609
PMC: 10824623.
DOI: 10.1111/iwj.14351.
Is fatty infiltration in paraspinal muscles reversible with exercise in people with low back pain? A systematic review.
Wesselink E, Pool J, Mollema J, Weber 2nd K, Elliott J, Coppieters M
Eur Spine J. 2022; 32(3):787-796.
PMID: 36459201
PMC: 10515728.
DOI: 10.1007/s00586-022-07471-w.
Real-World Therapy Management and Outcomes of First-Line Axitinib Plus Pembrolizumab in Patients With Advanced Renal Cell Carcinoma in the United States.
Zakharia Y, Thomaidou D, Li B, Siu G, Levin R, Vlahiotis A
Front Oncol. 2022; 12:861189.
PMID: 35664758
PMC: 9161634.
DOI: 10.3389/fonc.2022.861189.
Generalizability and Transportability of the National Lung Screening Trial Data: Extending Trial Results to Different Populations.
Inoue K, Hsu W, Arah O, Prosper A, Aberle D, Bui A
Cancer Epidemiol Biomarkers Prev. 2021; 30(12):2227-2234.
PMID: 34548326
PMC: 8643314.
DOI: 10.1158/1055-9965.EPI-21-0585.
Target validity: Bringing treatment of external validity in line with internal validity.
Lesko C, Ackerman B, Webster-Clark M, Edwards J
Curr Epidemiol Rep. 2021; 7(3):117-124.
PMID: 33585162
PMC: 7879946.
DOI: 10.1007/s40471-020-00239-0.
Assessing the uncertainty of treatment outcomes in a previous systematic review of venous leg ulcer randomized controlled trials: Additional secondary analysis.
Eckert K, Carter M
Wound Repair Regen. 2021; 29(2):327-334.
PMID: 33556200
PMC: 7986240.
DOI: 10.1111/wrr.12897.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?.
Jimenez-Fonseca P, Carmona-Bayonas A, de Castro E, Custodio A, Pericay Pijaume C, Hernandez R
Gastric Cancer. 2020; 24(2):445-456.
PMID: 32970266
PMC: 7902567.
DOI: 10.1007/s10120-020-01116-x.
Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data.
Moran M, Nickens D, Adcock K, Bennetts M, Desscan A, Charnley N
Target Oncol. 2019; 14(4):405-416.
PMID: 31301015
PMC: 6684538.
DOI: 10.1007/s11523-019-00653-5.
Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population.
Stewart R, MacDonald B, Chu T, Moore J, Fasanmi E, Ojha R
Dig Dis Sci. 2018; 63(12):3233-3240.
PMID: 30014226
PMC: 6244975.
DOI: 10.1007/s10620-018-5205-2.
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort.
Smith A, Howell D, Crouch S, Painter D, Blase J, Wang H
Int J Epidemiol. 2018; 47(3):700-700g.
PMID: 29618056
PMC: 6005016.
DOI: 10.1093/ije/dyy044.
A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial.
Donovan J, Young G, Walsh E, Metcalfe C, Athene Lane J, Martin R
J Clin Epidemiol. 2017; 96:35-46.
PMID: 29288137
PMC: 5854278.
DOI: 10.1016/j.jclinepi.2017.12.019.
Advancing 'real-world' trials that take account of social context and human volition.
Hansen A, Jones A
Trials. 2017; 18(1):531.
PMID: 29126449
PMC: 5681782.
DOI: 10.1186/s13063-017-2286-8.
Generalizing Study Results: A Potential Outcomes Perspective.
Lesko C, Buchanan A, Westreich D, Edwards J, Hudgens M, Cole S
Epidemiology. 2017; 28(4):553-561.
PMID: 28346267
PMC: 5466356.
DOI: 10.1097/EDE.0000000000000664.
Randomised trials comparing different healthcare settings: an exploratory review of the impact of pre-trial preferences on participation, and discussion of other methodological challenges.
Corbett M, Watson J, Eastwood A
BMC Health Serv Res. 2016; 16(1):589.
PMID: 27756285
PMC: 5069828.
DOI: 10.1186/s12913-016-1823-6.
Improving precision medicine using individual patient data from trials.
Cahan A, Cimino J
CMAJ. 2016; 189(5):E204-E207.
PMID: 27573743
PMC: 5289871.
DOI: 10.1503/cmaj.160267.
